KPV KP10 10mg*10vials

KPV KP10 10mg*10 vials (lysine-proline-valine) is a highly effective, upgraded anti-inflammatory and immunomodulatory tripeptide, belonging to the repair peptide category. It is an enhanced intermediate version of the basic product KP5 5mg. This optimized short-chain tripeptide is derived from the bioactive core fragment of endogenous α-MSH, exhibiting zero immunogenicity, excellent biochemical stability, and a receptor-independent targeted inflammatory suppression mechanism. Compared to the standard version, KP10 10mg has doubled the effective concentration, comprehensively enhancing the inhibition of the NF-κB/MAPK dual inflammatory pathway, mucosal repair, neuroinflammatory stabilization, and immune homeostasis regulation. Overcoming the limitations of limited intervention effects in low-dose formulations, this highly effective, upgraded barrier-enhancing product can more deeply purify the inflammatory microenvironment and has a stronger barrier reconstruction capacity. It is perfectly suited for constructing models of moderate chronic inflammatory lesions, intervening in intestinal mucosal damage, regulating recurrent skin inflammation, and conducting synergistic anti-inflammatory studies of peptide complexes. It is a core upgraded preclinical research material for in-depth research into inflammatory pharmacology and barrier immune mechanisms.

Product Functions and Research Value

In high-intensity systemic laboratory studies, KPV KP10 10mg stably blocks the activation of two core inflammatory signaling pathways (NF-κB and MAPK) in vivo, significantly inhibiting the overexpression of various pro-inflammatory cytokines and chemokines. Its core upgraded research advantages encompass four enhanced dimensions: deep inhibition of chronic persistent inflammation, enhanced reconstruction of mucosal and intestinal barrier damage, complete relief of recurrent skin inflammatory lesions, and long-term stabilization of systemic immune homeostasis. Unlike the mild basal regulatory effect of KP5, KP10 10mg exhibits faster experimental phenotypic responses, stronger inflammatory signal blocking efficiency, and more durable barrier repair efficacy. It effectively improves moderately refractory inflammatory phenotypes, such as recurrent dermatitis, persistent mucosal erosion, and low-grade inflammatory infiltration. It stabilizes IκB protein activity, prevents excessive nuclear translocation of NF-κB, and fundamentally inhibits inflammatory gene transcription; simultaneously, it inhibits excessive activation of glial cells, reduces moderate neuroinflammatory stress, and protects the physiological stability of nerve and epithelial tissues. The 10mg high-efficiency balanced formulation exhibits significant experimental variability and stable long-term efficacy output, making it ideal for medium-to-high dose gradient threshold screening, modeling of moderate inflammatory disease mechanisms, and validation of complex peptide synergistic anti-inflammatory effects. It provides highly discriminative and authoritative data for in-depth research in inflammatory immunology.

Core Product Advantages

1. Doubled Potency Targeted Inflammation Inhibition: The effective concentration is doubled compared to the standard 5mg dose, comprehensively enhancing the inhibitory capacity of the NF-κB/MAPK dual pathway, completely overcoming the limitations of the basic low-dose KPV formulation's limited efficacy.

2. Independent High-Precision Anti-inflammatory Mechanism: It possesses receptor-independent transcriptional-level inflammatory regulation characteristics, precisely inhibiting pathological inflammation without interfering with normal immune function, achieving high-precision inflammatory homeostasis intervention without immunosuppressive side effects.

3. Enhanced Barrier Repair and Neuroinflammatory Dual Repair: It further enhances the skin and intestinal mucosal barrier reconstruction capacity, while simultaneously enhancing the relief of moderate neuroinflammatory inflammation, covering scenarios of moderate-to-deep inflammatory damage repair that the basic formulation cannot effectively address. 4. High-stability pharmaceutical-grade purification process: Utilizing upgraded multi-stage gradient deep purification and vacuum freeze-drying lock technology, the active molecular structure is fully preserved, with zero impurity interference and ultra-pure experimental variables, ensuring the accuracy and reproducibility of high-level research conclusions.

5. Advanced standard aseptic packaging: 10 vials per integrated dust-free aseptic package. Each batch undergoes rigorous full-item HPLC purity testing and comes with a complete official Certificate of Account (COA). It possesses long-term stable activity retention characteristics and is widely applicable to high-level laboratory research on inflammation mechanisms, high-standard barrier immunity preclinical projects, and global high-end bulk customized procurement.

KPV KP10 10mg*10 vials